Recent Finacing
Recent Raise
CimCure develops vaccine-based cancer immunotherapies using its Immune-Boost (iBoost) conjugate technology to target tumor vasculature, with preclinical efficacy, planned phase 1–2 trials, and CDMO partner Intravacc.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor